跳至主要内容
临床试验/NL-OMON50012
NL-OMON50012已完成不适用

The effect of galacto-oligosaccharides on gut complaints without medical diagnosis (e.g. bloating, constipation, diarrhea) in adult women - Darmboost

Campina0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 25 - 45 years of age
  • - Component (summed) score for gut complaints * 6 (based on bloating,
  • flatulence, stomach ache, constipation, diarrhea)

排除标准

  • - Any medical diagnosed disease underlying gut-related complaints, including
  • Irritable Bowel Syndrome, celiac disease, Crohn*s disease, colitis,
  • haemorrhoids, cancer, and/or any other disease considered relevant as
  • determined during screening.
  • - Use of antibiotics, opiates, anti-inflammatory drugs (NSAIDs) and/or
  • metformin, and/or other medication that are known to affect the composition of
  • the gut microbiota during the 14 days before inclusion.
  • - Pregnant or lactating.
  • - Self-reported lactose intolerance
  • - Self-reported cow*s milk protein allergy.

研究者

发起方
Campina

相似试验